The Impact of Mitochondrial Dysfunction on Human Bone Cell Metabolism and Remodelling
Condition(s) studied
Investigational drug(s) / intervention(s)
Clinical assessment, blood samples, bone marrow and bone biopsy: Assessment of blood samples, bone marrow and bone biopsy
Study summary
Cell and mice studies suggest mitochondrial dysfunction may cause altered bone structure.
Hypothesis: Decreased mitochondrial energy production affects bone cell development and activity negatively.
Comparing humans with the mitochondrial DNA variant, m.3243A\>G, pathogenic variants in POLG or TWNK genes to healthy controls, the aim is to evaluate the effect of mitochondrial dysfunction on: 1: bone-cell development and -activity in bone marrow stem cells and blood.
2: bone cell metabolism including glucose consumption. 3: bone structure assessed by electron microscopy and μCT scans of bone biopsies.
Eligibility
Primary outcome measure(s)
- Extracellular acidification rate (ECAR) (mpH/min) — Up to 12 weeks
Measurement of ECAR in human bone marrow skeletal (mesenchymal) stem cells (hBM-MSCs), osteoblasts (OB) and osteoclasts (OC) - Oxygen consumption rate (OCR) (mpMol/min) — Up to 12 weeks
Measurement of OCR in hBM-MSCs, OBs and OCs - Growth rate (number of cells) — Up to 12 weeks
Growth rate of of OBs and OCs
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Dept. of Clinical Genetics | Aalborg | Denmark |
More Aalborg University Hospital trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05483738 on ClinicalTrials.gov ↗ ← All trials in Denmark